At-home Breast Oncology Care Delivered With E-health Solutions The ABODE Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Objective: To compare changes in patient activation (assessed by PAM-13) over 1 year among newly diagnosed breast cancer patients between those using the app and those receiving standard care. Secondary

Objectives: 1. Compare additional PROMs between the standard care and intervention groups 2. Describe health service outcomes among app users 3. Explore end-user experience of using the app 4. Measure activity levels using wearable devices

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Females (assigned female at birth)\*

• Diagnosed with first, primary invasive BC

• Must have surgery as their first step in treatment pathway

• Age≥18

• Access to an electronic device with connection to the internet

• A valid email address

• Can communicate in English \*Since BC risk is sex-related and based on physiological values, our inclusion criteria are based on sex (not gender)

Locations
Other Locations
Canada
Tulin Cil
RECRUITING
Toronto
Contact Information
Primary
Tulin Cil, MD, MEd
tulin.cil@uhn.ca
416-946-4507
Backup
Emma Reel, MSW
emma.reel@uhn.ca
647-202-1028
Time Frame
Start Date: 2023-06-22
Estimated Completion Date: 2026-06-22
Participants
Target number of participants: 200
Treatments
No_intervention: Control Arm
The control arm will receive standard treatment.
Experimental: Interventional Arm
Individuals within the intervention will receive standard care and access to the Breast Cancer Treatment Application (BCTA) for 13 months.
Related Therapeutic Areas
Sponsors
Leads: University Health Network, Toronto

This content was sourced from clinicaltrials.gov